<?xml version="1.0" encoding="UTF-8"?>
<p class="p">A cause for concern to the Canadian population and public health sector is the emergence and establishment or re-establishment of climate-sensitive infectious diseases, particularly Lyme disease (
 <xref rid="c5" ref-type="bibr" class="xref">Bush et al. 2014</xref>). Lyme disease is caused by the bacterium 
 <italic class="italic">Borrelia burgdorferi</italic> and is transmitted by ixodid ticks. The main vectors are 
 <italic class="italic">Ixodes pacifus</italic> and 
 <italic class="italic">Ixodes scapularis</italic> in western and central/eastern North America, respectively (
 <xref rid="c14" ref-type="bibr" class="xref">Eisen et al. 2016</xref>). Since the first reported human cases of Lyme disease in the early 1990s, Canada has experienced an increase in both the number of endemic regions for the disease and the number of annual diagnosed human cases (
 <xref rid="c37" ref-type="bibr" class="xref">Ogden et al. 2008</xref>; 
 <xref rid="c39" ref-type="bibr" class="xref">PHAC 2015</xref>). Not only are these trends placing increased health stress on the Canadian population, but they are also likely resulting in added economic consequences for patients, communities, the healthcare system, and governments (
 <xref rid="c18" ref-type="bibr" class="xref">Hinckley et al. 2014</xref>; 
 <xref rid="c1" ref-type="bibr" class="xref">Adrion et al. 2015</xref>; 
 <xref rid="c56" ref-type="bibr" class="xref">Zhang et al. 2006</xref>).
</p>
